Trials / Completed
CompletedNCT04400422
Experience of Using Lipano in Children With Fatty Acid Oxidation Disorders
Experience of Using Lipano in Children With LCHAD (Long Chain Fatty Acid Oxidation Disorder)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Dr. Schär AG / SPA · Industry
- Sex
- All
- Age
- 18 Months
- Healthy volunteers
- Not accepted
Summary
This is a market research, observational study to evaluate the tolerability and acceptability of an MCT based formula for infants and young people with long chain fatty acid oxidation disorder from birth to 18 months. Patients with a confirmed diagnosis of a fatty acid oxidation disorder, which requires a specialist diet including MCT will be included in this study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Lipano formula | Subjects will be asked to take an MCT infant formula to assess the tolerability, compliance and overall acceptability of the product for patient with LCHAD |
Timeline
- Start date
- 2018-06-20
- Primary completion
- 2018-09-20
- Completion
- 2018-09-20
- First posted
- 2020-05-22
- Last updated
- 2020-05-22
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT04400422. Inclusion in this directory is not an endorsement.